| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |